A recent order issued in the in the U.S. District Court, District of Minnesota has laid the groundwork for establishing a leadership structure in the federal Stryker hip recall litigation’s Plaintiffs’ counsel, according to court records.

The Order dated October 9th is requiring that all attorneys who have been proposed as co-lead counsel file a memorandum with the Court by the following week detailing why they should be appointed lead counsel. As of September 2013, at least 290 Stryker lawsuit claims, filed over the now-recalled Rejuvenate and ABG II modular-neck hip stems, are now pending in the federal proceeding. These cases allege pain, swelling, metallosis and other hip failure complications often necessitating revision surgery. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)

The latest status conference in the federal Stryker lawsuit litigation was held on September 9th, and began the process for proposing leadership positions in the Plaintiffs’ counsel. Following the October 15th deadline set for attorney leadership position proposals, a calendar posted on the Court’s website indicates that the proceeding’s next status conference will be held on November 21st at 9:00 a.m.

Stryker Recall Prompts the Filing of 600+ Lawsuits in the U.S.

Hundreds of Stryker lawsuit filings are now pending at the state court level. According to a recent update, at least 382 cases over the Rejuvenate and ABG II modular-neck hip stems were pending in a multicounty litigation established in Bergen County Superior Court as of September 24th, 2013.

All cases filed in these proceedings were brought on behalf of individuals affected by the Stryker recall, which was issued on July 6, 2012 and affected some 20,000 Stryker Rejuvenate and ABG II hip stems. Stryker Orthopaedics announced the recall after post-surveillance data showed the potential for metal components of the device to fret and corrode at the modular-neck junction. In turn, metallic debris may break off and shed into the recipient’s blood stream, hundreds of lawsuits now allege.

Since last year, the manufacturer has advised all recipients of the Rejuvenate and ABG II hip implants to monitor for complications associated with metallosis. On its website, Stryker has recommended routine cross-sectional imaging and blood testing for all hip recipients, whether or not they are experiencing symptoms.

Were You Affected by the Stryker Recall? Call Us Now.

If you experienced pain, swelling, or another complication following implantation of the Stryker Rejuvenate or ABG II implants, dial one of our lawyers at (877) 779-1414 for a free case evaluation today.

Published October 11, 2013 by